Fig. 2From: FROP-1 peptide-conjugated ultrasmall superparamagnetic nanoparticles as a targeted T1-weighted MR contrast agent for breast cancer: in vitro study(a) XRD; (b) EDX and; (c) magnetization curves of Fe3O4NPsBack to article page
